Burning Rock Biotech

BNR

Q2 FY2026 Earnings

Financial report interval: 2026.03.30 - 2026.06.30

Overview: Burning Rock Biotech(BNR) the Revenue is 19.85 M (-4.18%);the EBIT is -2.651 M (-65.38%);the EPS is -0.25 (-98.73%).

Actual
YoY
Estimate
YoY
Vs estimate
YoY
Revenue
0.02B4.18%
----
----
EBIT
-0.00B65.38%
----
----
EPS
-0.249698.73%
----
----

Upcoming earnings report - Q3 FY2026

Available dateNov 20, 2026
Estimate Revenue--
Estimate EBIT--
Estimate EPS--

Revenue

ActualEstimateUnit: USD
Quarterly

EBIT

ActualEstimateUnit: USD
Quarterly

Net income

ActualEstimateUnit: USD
Quarterly

EPS

ActualEstimateUnit: USD
Quarterly